IOVA vs J · rev $170.7M vs P/E 36, rev $4.08B
Iovance Biotherapeutics Inc (IOVA) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported IOVA revenue for 2026-06-30 was $170.7M. Net income was -$126.4M. IOVA currently screens at market cap $1.89B.
Latest reported J revenue for 2026-06-26 was $4.08B. Net income was $136.6M. Revenue was down 41.7% from 2026-03-27 to 2026-06-26. J currently screens at market cap $14.40B and trailing P/E 36.0.
IOVA currently screens at market cap $1.89B. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the IOVA and J stock pages for the full models.
Not investment advice.